Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis

BACKGROUND: The treatment success rate of conventional anti-tuberculosis (TB) regimens for extensively drug-resistant TB (XDR-TB) is low, resulting in high morbidity and healthcare cost especially in the high TB burden countries. Recent clinical findings reported improved treatment outcomes of XDR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekadu, Ginenus, Yao, Jiaqi, You, Joyce H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355220/
https://www.ncbi.nlm.nih.gov/pubmed/35930574
http://dx.doi.org/10.1371/journal.pone.0272770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355220/
https://www.ncbi.nlm.nih.gov/pubmed/35930574
http://dx.doi.org/10.1371/journal.pone.0272770

Ejemplares similares